We all hope that our arteries look like this one Clear of obstruction, compliant and no blockage No physical symptoms always equal healthy arteries?
We all hope our arteries never look like this one
Extreme buildup of plaque, lack of compliance, and significant restrictions of blood flow
Physical symptoms always go along with unhealthy arteries?
50% of the deaths in the US come from coronary artery disease
50% of those deaths occur with no prior physical symptoms
Peace of mind comes from knowing the health of your arteries.
As you age, there is a way to achieve this
We are a medical distribution and sales company with the rights to market a truly disruptive diagnostic testing device that we believe has the ability to dramatically change mortality rates.Through extensive research we have developed a unique approach to making our device available which creates a win-win for medical professionals, our sales team and the patients.Learn More
Kardia Technologies is the distributor of the Soteria Cardiac Platform ™; a patented medical non-invasive testing device for coronary artery disease. The Platform's revolutionary test, The Soterogram ™, provides the physician with an accurate way to measure arterial health.Learn More
We are interested in partnering with existing medical device distributors in the distribution of our products including the Soteria Cardiac Platform ™ and the Soterogram ™. If you operate a medical sales and distribution company and have an interest in partnering with Kardia, reach out to us.Learn More
Would you like to work for a Company that is changing average life expectancy? We are growing and expanding and hiring to support our growth. We are interested in professionals both in sales and operations. Are you interested in a new opportunity with an innovative organization that you can grow with?Learn More
Until now, physicians had to wait until their patients exhibited symptoms of coronary artery disease before they prescribed treatment or lifestyle changes or resort to expensive invasive testing to determine if the patient has the start of issues with their arteries. Unfortunately, for many individuals this is too late. 50% of the deaths due to coronary artery disease occur in individuals that have shown no outward symptoms and their death results from an initial incident.
Now there is a simple accurate non-invasive test that can be used to determine if the patient is developing coronary artery disease and needs to take steps to avoid significant health issues or death. Kardia Technologies brings this breakthrough to the medical community. The power of this test creates opportunities for physician practices, medical device distribution companies, and sales and operations professionals that want to be part of an innovative organization that can and will change lives of individuals.